Syncom Formulations India Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 12, 2026

Key Highlights

The Latest Trading Price of Syncom Formulations (India) Ltd is ₹ 14.29 as of 12 Jun 15:30 . The P/E Ratio of Syncom Formulations (India) Ltd changed from 46.2 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 60.9 on March 2022 to 66 on March 2026 . This represents a CAGR of 1.35% over 6 years The Market Cap of Syncom Formulations (India) Ltd changed from ₹ 916.79 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 47318 crore on March 2022 to ₹ 142845 crore on March 2026 . This represents a CAGR of 20.22% over 6 years The revenue of Syncom Formulations (India) Ltd for the Mar '26 is ₹ 149.97 crore as compare to the Dec '25 revenue of ₹ 120.64 crore. This represent the growth of 24.31% The revenue of Torrent Pharmaceuticals Ltd for the Mar '26 is ₹ 4180 crore as compare to the Dec '25 revenue of ₹ 3290 crore. This represent the growth of 27.05% The ebitda of Syncom Formulations (India) Ltd for the Mar '26 is ₹ 36.56 crore as compare to the Dec '25 ebitda of ₹ 26.71 crore. This represent the growth of 36.88% The ebitda of Torrent Pharmaceuticals Ltd for the Mar '26 is ₹ 1273 crore as compare to the Dec '25 ebitda of ₹ 1065 crore. This represent the growth of 19.53% The net profit of Syncom Formulations (India) Ltd changed from ₹ 7.63 crore to ₹ 25.17 crore over 8 quarters. This represents a CAGR of 81.63% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 457 crore to ₹ 364 crore over 8 quarters. This represents a CAGR of -10.75% The Dividend Payout of Syncom Formulations (India) Ltd changed from 13.07 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 52.06 % on March 2021 to 58.69 % on March 2026 . This represents a CAGR of 2.02% over 6 years .

About Syncom Formulations (India) Ltd

Incorporated as a private limited Company in 1988, Syncom Formulations (India) Limited was converted into a public limited Company in June, 1992.
The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency.
Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations.

About Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 15 countries with major setups in the US, Germany and Brazil.

FAQs for the comparison of Syncom Formulations (India) Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Syncom Formulations (India) Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Syncom Formulations (India) Ltd is 1,304 Cr while Market cap of Torrent Pharmaceuticals Ltd is 154,669 Cr

What are the key factors driving the stock performance of Syncom Formulations (India) Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Syncom Formulations (India) Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Syncom Formulations (India) Ltd and Torrent Pharmaceuticals Ltd?

As of June 12, 2026, the Syncom Formulations (India) Ltd stock price is INR ₹13.88. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹4570.0.

How do dividend payouts of Syncom Formulations (India) Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Syncom Formulations (India) Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.